[Comparison of follow-up treatment regimens for colorectal cancer liver metastases without objective response to neoadjuvant chemotherapy: direct surgery or surgery after second-line chemotherapy].

Lyu, X Y; Bi, X Y; Zhao, H; Chen, Q C; Luo, Z W; Zhang, B L; Zhang, X S; Cai, J Q

Lyu, X Y; Bi, X Y; Zhao, H; Chen, Q C; Luo, Z W; Zhang, B L; Zhang, X S; Cai, J Q.

Afiliação

Lyu XY; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Bi XY; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Zhao H; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Chen QC; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Luo ZW; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Zhang BL; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Zhang XS; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.
Cai JQ; Department of Hepatobiliary Surgery,Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,National Cancer Center,National Clinical Research Center for Cancer,Beijing 100021,China.

Zhonghua Wai Ke Za Zhi ; 60(5): 454-460, 2022 May 01.

Article em Zh | MEDLINE | ID: mdl-35359087

Assuntos

Neoplasias Colorretais; Neoplasias Hepáticas; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Estudos de Coortes; Neoplasias Colorretais/patologia; Feminino; Seguimentos; Humanos; Neoplasias Hepáticas/secundário; Masculino; Pessoa de Meia-Idade; Terapia Neoadjuvante; Prognóstico; Estudos Retrospectivos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Neoplasias Hepáticas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: Zh Revista: Zhonghua Wai Ke Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google